Endurant Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-158,721
| Closed | -$11.3M | – | 58 |
|
|
2022
Q3 | $11.3M | Buy |
+158,721
| New | +$11.3M | 3.67% | 10 |
|
|
2022
Q2 | – | Sell |
-194,684
| Closed | -$14.2M | – | 53 |
|
|
2022
Q1 | $14.2M | Buy |
+194,684
| New | +$14.2M | 3.75% | 5 |
|
|
2021
Q4 | – | Sell |
-211,821
| Closed | -$12.5M | – | 69 |
|
|
2021
Q3 | $12.5M | Buy |
211,821
+110,740
| +110% | +$6.55M | 2.85% | 7 |
|
|
2021
Q2 | $6.75M | Sell |
101,081
-132,817
| -57% | -$8.87M | 1.86% | 20 |
|
|
2021
Q1 | $14.8M | Sell |
233,898
-10,168
| -4% | -$642K | 3.85% | 3 |
|
|
2020
Q4 | $15.1M | Sell |
244,066
-146,090
| -37% | -$9.06M | 5.46% | 3 |
|
|
2020
Q3 | $23.5M | Buy |
390,156
+354,047
| +980% | +$21.3M | 6.96% | 1 |
|
|
2020
Q2 | $2.12M | Sell |
36,109
-100,816
| -74% | -$5.93M | 0.12% | 37 |
|
|
2020
Q1 | $7.63M | Sell |
136,925
-264,509
| -66% | -$14.7M | 3.46% | 11 |
|
|
2019
Q4 | $25.8M | Buy |
401,434
+109,509
| +38% | +$7.03M | 8.12% | 1 |
|
|
2019
Q3 | $14.8M | Buy |
291,925
+205,628
| +238% | +$10.4M | 5.31% | 6 |
|
|
2019
Q2 | $3.91M | Sell |
86,297
-204,984
| -70% | -$9.3M | 1.54% | 28 |
|
|
2019
Q1 | $13.9M | Buy |
291,281
+241,944
| +490% | +$11.5M | 5.49% | 1 |
|
|
2018
Q4 | $2.57M | Sell |
49,337
-28,634
| -37% | -$1.49M | 1.36% | 23 |
|
|
2018
Q3 | $4.84M | Buy |
+77,971
| New | +$4.84M | 2.15% | 15 |
|